Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy in Children—A Literature Review
Open Access
- 29 January 2024
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (3) , 780
Abstract
Vagus nerve stimulation (VNS) is a palliative treatment for drug-resistant epilepsy (DRE) that has been in use for over two decades. VNS suppresses epileptic seizures, prevents emotional disorders, and improves cognitive function and sleep quality, a parallel effect associated with the control of epileptic seizures. The seizure suppression rate with VNS increases monthly to annually, and the incidence of side effects reduces over time. This method is effective in treating DRE in children as well as adults, such as epilepsy associated with tuberous sclerosis, Dravet syndrome, and Lennox–Gastaut syndrome. In children, it has been reported that seizures decreased by >70% approximately 8 years after initiating VNS, and the 50% responder rate was reported to be approximately 70%. VNS regulates stimulation and has multiple useful systems, including self-seizure suppression using magnets, additional stimulation using an automatic seizure detection system, different stimulation settings for day and night, and an automatic stimulation adjustment system that reduces hospital visits. VNS suppresses seizures and has beneficial behavioral effects in children with DRE. This review describes the VNS system, the mechanism of the therapeutic effect, the specific stimulation adjustment method, antiepileptic effects, and other clinical effects in patients with childhood DRE.Keywords
Funding Information
- Grant-in-Aid for Scientific Research (C) (20K08223, 18K15700)
- Grant-in-Aid for Early-Career Scientists (20K08223, 18K15700)
This publication has 50 references indexed in Scilit:
- Electroclinical pattern in MECP2 duplication syndrome: Eight new reported cases and review of literatureEpilepsia, 2012
- The core Dravet syndrome phenotypeEpilepsia, 2011
- Efficacy of vagus nerve stimulation over time: Review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS >10yearsEpilepsy & Behavior, 2011
- Vagus Nerve Stimulation in Refractory Epilepsy: Effects on Pro- and Anti-Inflammatory Cytokines in Peripheral BloodNeuroimmunomodulation, 2010
- Vagus nerve stimulation for intractable epilepsy in tuberous sclerosis complexEpilepsy & Behavior, 2008
- Outcome Measurement after Vagal Nerve Stimulation Therapy: Proposal of a New ClassificationEpilepsia, 2007
- Vagus nerve stimulation for treatment of epilepsy in Rett syndromeDevelopmental Medicine & Child Neurology, 2006
- Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndromeJournal of Medical Genetics, 2005
- Brain Blood‐flow Alterations Induced by Therapeutic Vagus Nerve Stimulation in Partial Epilepsy: II. Prolonged Effects at High and Low Levels of StimulationEpilepsia, 2004
- Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizuresEpilepsy Research, 1995